John Hopkins Center for Psychedelic and Consciousness Research
Johns Hopkins University academics just a got a boost in their funding thanks to the recently launched Roland R. Griffiths Ph.D. Professorship Fund.
Psycheceutical enters into agreement with iNGENū to conduct human clinical trials of NeuroDirect™ ketamine topical in Australia
Phase I trial will study 20 people to...
Therapy’s a trip for these Wall Street executives.
Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out the hallucinogenic drug in a lavish setting to...
Psychedelic Drug Helped People with Alcohol use Disorder Reduce Drinking, Study Shows (Today)
Psilocybin, the ingredient in magic mushrooms, along with talk...
MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will accept delivery of...
Microdose’s Wonderland: Miami Conference to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 7-9, 2021.
Wonderland: Miami
MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...
